MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-12-31, INM made $820,188 in revenue. -$2,028,223 in net income. Net profit margin of -247.29%.

Income Overview

Revenue
$820,188
Net Income
-$2,028,223
Net Profit Margin
-247.29%
EPS
-$0.51
Unit: Dollar

Income Statement
2025-12-31
2025-09-30
2025-06-30
2025-03-31
Sales
820,188 1,120,121 1,888,838.5* -
Cost of sales
635,994 716,962 922,372* -
Gross profit
184,194 403,159 966,466.5* 0
Research and development
630,636 581,612 540,380* -
General and administrative
1,621,095 1,532,015 5,906,910.5* -
Amortization and depreciation
53,201 53,202 49,102* -
Foreign exchange loss (gain)
18,136 -56,994 -7,117.75* -
Total operating expenses
2,286,796 2,223,823 6,503,510.25* 0
Interest and other income
74,379 93,765 -15,400* -
Finance expense
--92,887.25* -
Loss before income taxes
-2,028,223 -1,726,899 -5,645,331 0
Net loss for the period
-2,028,223 -1,726,899 -5,645,331 -
Basic EPS
-0.51 -0.44 -5.784 -1.94
Diluted EPS
-0.51 -0.44 -5.784 -1.94
Basic Average Shares
3,954,549 3,954,549 975,985* 1,095,973
Diluted Average Shares
3,954,549 3,954,549 975,985* 1,095,973
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss for theperiod-$2,028,223 Sales$820,188 Loss before incometaxes-$2,028,223 Gross profit$184,194 Interest and other income$74,379 Cost of sales$635,994 Total operatingexpenses$2,286,796 Foreign exchange loss(gain)$18,136 General andadministrative$1,621,095 Research and development$630,636 Amortization anddepreciation$53,201

InMed Pharmaceuticals Inc. (INM)

InMed Pharmaceuticals Inc. (INM)